glp-1 prescriptions growth slowing 2024 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP-1 Analogues Market Size, Share

Effects of medium- and long-chain structured triacylglycerol on the therapeutic efficacy of vitamin D on ulcerative colitis: a consideration for efficient lipid delivery systems

The better question is not just whether a pill sounds easier, but whether the medication, dosing rules, and monitoring fit your metabolic picture

Despite the significant potential and advantages of GLP-1RAs, they are inevitably accompanied by a range of possible adverse drug reactions (ADRs), as is the case with any medication

Nausea represents the most frequently reported gastrointestinal side effect, occurring in approximately 17-30% of patients depending on dose and indication, with higher rates typically seen at higher doses and in the weight management indication